According to Market IntelliX Research, the global market for Weight-loss Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Weight-loss Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Weight-loss Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Liquid segment holds a share about % in 2023 and will reach % in 2030; while in terms of sales channels, Online Sales has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Weight-loss Drugs include Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott and Kellogg Company, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Weight-loss Drugs. Report Highlights:
(1) Global Weight-loss Drugs market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Weight-loss Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Weight-loss Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Weight-loss Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Weight-loss Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Weight-loss Drugs, capacity, production and trends.
(7) Weight-loss Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Liquid
Powder
Softgels
Pills
Others
Market segment by sales channels, can be divided into
Online Sales
Hospitals and Clinics
Pharmacy
Others
Market segment by players, this report covers
Novo Nordisk
Currax
Ultimate life ltd
Wolfson Berg Ltd
Swiss Research Labs Ltd.
Roar Ambition
Health and Nutrition Ltd.
Abbott
Kellogg Company
Glanbia PLC
Ajinomoto Co. Inc.
Kraft Heinz Company
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
PepsiCo
Nestle
Amway Corp.
1 Market Overview
1.1 Weight-loss Drugs Definition
1.2 Global Weight-loss Drugs Market Size and Forecast
1.2.1 By Revenue, Global Weight-loss Drugs Market Size, 2019-2030
1.2.2 By Sales Volume, Global Weight-loss Drugs Market Size, 2019-2030
1.2.3 Global Weight-loss Drugs Price Trend, 2019-2030
1.3 China Weight-loss Drugs Market Size and Forecast
1.3.1 By Revenue, China Weight-loss Drugs Market Size, 2019-2030
1.3.2 By Sales Volume, China Weight-loss Drugs Market Size, 2019-2030
1.3.3 China Weight-loss Drugs Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Weight-loss Drugs Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Weight-loss Drugs Share in Global Market, 2019-2030
1.4.3 Weight-loss Drugs Market Size: China VS Global, 2019-2030
1.5 Weight-loss Drugs Market Dynamics
1.5.1 Weight-loss Drugs Market Drivers
1.5.2 Weight-loss Drugs Market Restraints
1.5.3 Weight-loss Drugs Industry Trends
1.5.4 Weight-loss Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Weight-loss Drugs Revenue by Company, 2019-2024
2.2 Global Weight-loss Drugs Sales Volume by Company, 2019-2024
2.3 Global Weight-loss Drugs Price by Company, 2019-2024
2.4 Global Weight-loss Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Weight-loss Drugs Concentration Ratio
2.6 Global Weight-loss Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Weight-loss Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Weight-loss Drugs Revenue by Company, 2019-2024
3.2 China Weight-loss Drugs Sales Volume by Company, 2019-2024
3.3 China Weight-loss Drugs Weight-loss Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Weight-loss Drugs Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Weight-loss Drugs Domestic VS Export
3.6 China Market, Weight-loss Drugs Import & Export
3.6.1 China Market, Weight-loss Drugs Import & Export, 2019-2030
3.6.2 China Weight-loss Drugs Import & Export Trends
3.6.3 Main Sources of China Weight-loss Drugs Import
3.6.4 Export Destination of China Weight-loss Drugs
4 Weight-loss Drugs Production by Region
4.1 Global Weight-loss Drugs Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Weight-loss Drugs Manufacturers
4.3 Global Major Manufacturers, Weight-loss Drugs Capacity Expansion and Future Plans
4.4 Global Weight-loss Drugs Capacity by Region
4.5 Global Weight-loss Drugs Production by Region
4.5.1 Global Weight-loss Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Weight-loss Drugs Production by Region, 2019-2024
4.5.3 Global Weight-loss Drugs Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Weight-loss Drugs Industry Chain
5.2 Weight-loss Drugs Upstream Analysis
5.2.1 Weight-loss Drugs Core Raw Materials
5.2.2 Main Manufacturers of Weight-loss Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Weight-loss Drugs Production Mode
5.6 Weight-loss Drugs Procurement Model
5.7 Weight-loss Drugs Industry Sales Model and Sales Channels
5.7.1 Weight-loss Drugs Sales Model
5.7.2 Weight-loss Drugs Typical Distributors
6 Sights by Type
6.1 Weight-loss Drugs Classification
6.1.1 Liquid
6.1.2 Powder
6.1.3 Softgels
6.1.4 Pills
6.1.5 Others
6.2 By Type, Global Weight-loss Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Weight-loss Drugs Revenue, 2019-2030
6.4 By Type, Global Weight-loss Drugs Sales Volume, 2019-2030
6.5 By Type, Global Weight-loss Drugs Price, 2019-2030
7 Sights by Sales Channels
7.1 Weight-loss Drugs Segment by Sales Channels
7.1.1 Online Sales
7.1.2 Hospitals and Clinics
7.1.3 Pharmacy
7.1.4 Others
7.2 By Application, Global Weight-loss Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Weight-loss Drugs Revenue, 2019-2030
7.4 By Application, Global Weight-loss Drugs Sales Volume, 2019-2030
7.5 By Application, Global Weight-loss Drugs Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Weight-loss Drugs Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Weight-loss Drugs Revenue, 2019-2030
8.3 By Region, Global Weight-loss Drugs Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Weight-loss Drugs Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Weight-loss Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Weight-loss Drugs Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Weight-loss Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Weight-loss Drugs Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Weight-loss Drugs Market Size Market Share
8.7 South America
8.7.1 South America Weight-loss Drugs Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Weight-loss Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Weight-loss Drugs Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global Weight-loss Drugs Revenue, 2019-2030
9.3 By Country, Global Weight-loss Drugs Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Weight-loss Drugs Market Size, 2019-2030
9.4.2 By Company, U.S. Weight-loss Drugs Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.4.4 By Sales Channels, U.S. Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Weight-loss Drugs Market Size, 2019-2030
9.5.2 By Company, Europe Weight-loss Drugs Sales Volume Market Share, 2023
9.5.3 By Type, Europe Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.5.4 By Sales Channels, Europe Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Weight-loss Drugs Market Size, 2019-2030
9.6.2 By Company, China Weight-loss Drugs Sales Volume Market Share, 2023
9.6.3 By Type, China Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.6.4 By Sales Channels, China Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Weight-loss Drugs Market Size, 2019-2030
9.7.2 By Company, Japan Weight-loss Drugs Sales Volume Market Share, 2023
9.7.3 By Type, Japan Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.7.4 By Sales Channels, Japan Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Weight-loss Drugs Market Size, 2019-2030
9.8.2 By Company, South Korea Weight-loss Drugs Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.8.4 By Sales Channels, South Korea Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Weight-loss Drugs Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Weight-loss Drugs Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.9.4 By Sales Channels, Southeast Asia Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Weight-loss Drugs Market Size, 2019-2030
9.10.2 By Company, India Weight-loss Drugs Sales Volume Market Share, 2023
9.10.3 By Type, India Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.10.4 By Sales Channels, India Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Weight-loss Drugs Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Weight-loss Drugs Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Weight-loss Drugs Market Size, Share, 2023 VS 2030
9.11.4 By Sales Channels, Middle East & Asia Weight-loss Drugs Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position
10.1.2 Novo Nordisk Weight-loss Drugs Models, Specifications and Application
10.1.3 Novo Nordisk Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Novo Nordisk Company Profile and Main Business
10.1.5 Novo Nordisk Recent Developments
10.2 Currax
10.2.1 Currax Company Information, Head Office, Market Area and Industry Position
10.2.2 Currax Weight-loss Drugs Models, Specifications and Application
10.2.3 Currax Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Currax Company Profile and Main Business
10.2.5 Currax Recent Developments
10.3 Ultimate life ltd
10.3.1 Ultimate life ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 Ultimate life ltd Weight-loss Drugs Models, Specifications and Application
10.3.3 Ultimate life ltd Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Ultimate life ltd Company Profile and Main Business
10.3.5 Ultimate life ltd Recent Developments
10.4 Wolfson Berg Ltd
10.4.1 Wolfson Berg Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Wolfson Berg Ltd Weight-loss Drugs Models, Specifications and Application
10.4.3 Wolfson Berg Ltd Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Wolfson Berg Ltd Company Profile and Main Business
10.4.5 Wolfson Berg Ltd Recent Developments
10.5 Swiss Research Labs Ltd.
10.5.1 Swiss Research Labs Ltd. Company Information, Head Office, Market Area and Industry Position
10.5.2 Swiss Research Labs Ltd. Weight-loss Drugs Models, Specifications and Application
10.5.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Swiss Research Labs Ltd. Company Profile and Main Business
10.5.5 Swiss Research Labs Ltd. Recent Developments
10.6 Roar Ambition
10.6.1 Roar Ambition Company Information, Head Office, Market Area and Industry Position
10.6.2 Roar Ambition Weight-loss Drugs Models, Specifications and Application
10.6.3 Roar Ambition Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Roar Ambition Company Profile and Main Business
10.6.5 Roar Ambition Recent Developments
10.7 Health and Nutrition Ltd.
10.7.1 Health and Nutrition Ltd. Company Information, Head Office, Market Area and Industry Position
10.7.2 Health and Nutrition Ltd. Weight-loss Drugs Models, Specifications and Application
10.7.3 Health and Nutrition Ltd. Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Health and Nutrition Ltd. Company Profile and Main Business
10.7.5 Health and Nutrition Ltd. Recent Developments
10.8 Abbott
10.8.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.8.2 Abbott Weight-loss Drugs Models, Specifications and Application
10.8.3 Abbott Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Abbott Company Profile and Main Business
10.8.5 Abbott Recent Developments
10.9 Kellogg Company
10.9.1 Kellogg Company Company Information, Head Office, Market Area and Industry Position
10.9.2 Kellogg Company Weight-loss Drugs Models, Specifications and Application
10.9.3 Kellogg Company Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Kellogg Company Company Profile and Main Business
10.9.5 Kellogg Company Recent Developments
10.10 Glanbia PLC
10.10.1 Glanbia PLC Company Information, Head Office, Market Area and Industry Position
10.10.2 Glanbia PLC Weight-loss Drugs Models, Specifications and Application
10.10.3 Glanbia PLC Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Glanbia PLC Company Profile and Main Business
10.10.5 Glanbia PLC Recent Developments
10.11 Ajinomoto Co. Inc.
10.11.1 Ajinomoto Co. Inc. Company Information, Head Office, Market Area and Industry Position
10.11.2 Ajinomoto Co. Inc. Weight-loss Drugs Models, Specifications and Application
10.11.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Ajinomoto Co. Inc. Company Profile and Main Business
10.11.5 Ajinomoto Co. Inc. Recent Developments
10.12 Kraft Heinz Company
10.12.1 Kraft Heinz Company Company Information, Head Office, Market Area and Industry Position
10.12.2 Kraft Heinz Company Weight-loss Drugs Models, Specifications and Application
10.12.3 Kraft Heinz Company Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Kraft Heinz Company Company Profile and Main Business
10.12.5 Kraft Heinz Company Recent Developments
10.13 GlaxoSmithKline PLC
10.13.1 GlaxoSmithKline PLC Company Information, Head Office, Market Area and Industry Position
10.13.2 GlaxoSmithKline PLC Weight-loss Drugs Models, Specifications and Application
10.13.3 GlaxoSmithKline PLC Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 GlaxoSmithKline PLC Company Profile and Main Business
10.13.5 GlaxoSmithKline PLC Recent Developments
10.14 Herbalife Nutrition Ltd.
10.14.1 Herbalife Nutrition Ltd. Company Information, Head Office, Market Area and Industry Position
10.14.2 Herbalife Nutrition Ltd. Weight-loss Drugs Models, Specifications and Application
10.14.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Herbalife Nutrition Ltd. Company Profile and Main Business
10.14.5 Herbalife Nutrition Ltd. Recent Developments
10.15 PepsiCo
10.15.1 PepsiCo Company Information, Head Office, Market Area and Industry Position
10.15.2 PepsiCo Weight-loss Drugs Models, Specifications and Application
10.15.3 PepsiCo Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 PepsiCo Company Profile and Main Business
10.15.5 PepsiCo Recent Developments
10.16 Nestle
10.16.1 Nestle Company Information, Head Office, Market Area and Industry Position
10.16.2 Nestle Weight-loss Drugs Models, Specifications and Application
10.16.3 Nestle Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Nestle Company Profile and Main Business
10.16.5 Nestle Recent Developments
10.17 Amway Corp.
10.17.1 Amway Corp. Company Information, Head Office, Market Area and Industry Position
10.17.2 Amway Corp. Weight-loss Drugs Models, Specifications and Application
10.17.3 Amway Corp. Weight-loss Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Amway Corp. Company Profile and Main Business
10.17.5 Amway Corp. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Weight-loss Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Weight-loss Drugs Market Restraints
Table 3. Weight-loss Drugs Market Trends
Table 4. Weight-loss Drugs Industry Policy
Table 5. Global Weight-loss Drugs Revenue by Company, 2019-2024, US$ million
Table 6. Global Weight-loss Drugs Revenue Market Share by Company, 2019-2024
Table 7. Global Weight-loss Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Weight-loss Drugs Sales Volume Market Share by Company, 2019-2024
Table 9. Global Weight-loss Drugs Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Weight-loss Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Weight-loss Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Weight-loss Drugs Manufacturers Product Type
Table 13. China Weight-loss Drugs Revenue by Company, 2019-2024, US$ million
Table 14. China Weight-loss Drugs Revenue Market Share by Company, 2019-2024
Table 15. China Weight-loss Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Weight-loss Drugs Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Weight-loss Drugs Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Weight-loss Drugs Import & Export Trends
Table 19. Main Sources of China Weight-loss Drugs Import
Table 20. Export Destination of China Weight-loss Drugs
Table 21. Global Headquarters and Manufacturing Base of Weight-loss Drugs Manufacturers
Table 22. Global Major Manufacturers, Weight-loss Drugs Capacity Expansion and Future Plans
Table 23. Global Weight-loss Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Weight-loss Drugs Production by Region, 2019-2024, (K Units)
Table 25. Global Weight-loss Drugs Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Weight-loss Drugs Upstream (Raw Materials)
Table 27. Global Weight-loss Drugs Typical Customers
Table 28. Weight-loss Drugs Typical Distributors
Table 29. By Type, Global Weight-loss Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Sales Channels, Global Weight-loss Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Weight-loss Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Weight-loss Drugs Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Weight-loss Drugs Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Weight-loss Drugs Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Weight-loss Drugs Revenue Market Share, 2019-2030
Table 37. By Country, Global Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Weight-loss Drugs Sales Volume Market Share, 2019-2030
Table 39. Novo Nordisk Company Information, Head Office, Market Area and Industry Position
Table 40. Novo Nordisk Weight-loss Drugs Models, Specifications and Application
Table 41. Novo Nordisk Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Novo Nordisk Company Profile and Main Business
Table 43. Novo Nordisk Recent Developments
Table 44. Currax Company Information, Head Office, Market Area and Industry Position
Table 45. Currax Weight-loss Drugs Models, Specifications and Application
Table 46. Currax Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Currax Company Profile and Main Business
Table 48. Currax Recent Developments
Table 49. Ultimate life ltd Company Information, Head Office, Market Area and Industry Position
Table 50. Ultimate life ltd Weight-loss Drugs Models, Specifications and Application
Table 51. Ultimate life ltd Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Ultimate life ltd Company Profile and Main Business
Table 53. Ultimate life ltd Recent Developments
Table 54. Wolfson Berg Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Wolfson Berg Ltd Weight-loss Drugs Models, Specifications and Application
Table 56. Wolfson Berg Ltd Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Wolfson Berg Ltd Company Profile and Main Business
Table 58. Wolfson Berg Ltd Recent Developments
Table 59. Swiss Research Labs Ltd. Company Information, Head Office, Market Area and Industry Position
Table 60. Swiss Research Labs Ltd. Weight-loss Drugs Models, Specifications and Application
Table 61. Swiss Research Labs Ltd. Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Swiss Research Labs Ltd. Company Profile and Main Business
Table 63. Swiss Research Labs Ltd. Recent Developments
Table 64. Roar Ambition Company Information, Head Office, Market Area and Industry Position
Table 65. Roar Ambition Weight-loss Drugs Models, Specifications and Application
Table 66. Roar Ambition Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Roar Ambition Company Profile and Main Business
Table 68. Roar Ambition Recent Developments
Table 69. Health and Nutrition Ltd. Company Information, Head Office, Market Area and Industry Position
Table 70. Health and Nutrition Ltd. Weight-loss Drugs Models, Specifications and Application
Table 71. Health and Nutrition Ltd. Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Health and Nutrition Ltd. Company Profile and Main Business
Table 73. Health and Nutrition Ltd. Recent Developments
Table 74. Abbott Company Information, Head Office, Market Area and Industry Position
Table 75. Abbott Weight-loss Drugs Models, Specifications and Application
Table 76. Abbott Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Abbott Company Profile and Main Business
Table 78. Abbott Recent Developments
Table 79. Kellogg Company Company Information, Head Office, Market Area and Industry Position
Table 80. Kellogg Company Weight-loss Drugs Models, Specifications and Application
Table 81. Kellogg Company Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Kellogg Company Company Profile and Main Business
Table 83. Kellogg Company Recent Developments
Table 84. Glanbia PLC Company Information, Head Office, Market Area and Industry Position
Table 85. Glanbia PLC Weight-loss Drugs Models, Specifications and Application
Table 86. Glanbia PLC Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Glanbia PLC Company Profile and Main Business
Table 88. Glanbia PLC Recent Developments
Table 89. Ajinomoto Co. Inc. Company Information, Head Office, Market Area and Industry Position
Table 90. Ajinomoto Co. Inc. Weight-loss Drugs Models, Specifications and Application
Table 91. Ajinomoto Co. Inc. Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Ajinomoto Co. Inc. Company Profile and Main Business
Table 93. Ajinomoto Co. Inc. Recent Developments
Table 94. Kraft Heinz Company Company Information, Head Office, Market Area and Industry Position
Table 95. Kraft Heinz Company Weight-loss Drugs Models, Specifications and Application
Table 96. Kraft Heinz Company Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Kraft Heinz Company Company Profile and Main Business
Table 98. Kraft Heinz Company Recent Developments
Table 99. GlaxoSmithKline PLC Company Information, Head Office, Market Area and Industry Position
Table 100. GlaxoSmithKline PLC Weight-loss Drugs Models, Specifications and Application
Table 101. GlaxoSmithKline PLC Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. GlaxoSmithKline PLC Company Profile and Main Business
Table 103. GlaxoSmithKline PLC Recent Developments
Table 104. Herbalife Nutrition Ltd. Company Information, Head Office, Market Area and Industry Position
Table 105. Herbalife Nutrition Ltd. Weight-loss Drugs Models, Specifications and Application
Table 106. Herbalife Nutrition Ltd. Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Herbalife Nutrition Ltd. Company Profile and Main Business
Table 108. Herbalife Nutrition Ltd. Recent Developments
Table 109. PepsiCo Company Information, Head Office, Market Area and Industry Position
Table 110. PepsiCo Weight-loss Drugs Models, Specifications and Application
Table 111. PepsiCo Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. PepsiCo Company Profile and Main Business
Table 113. PepsiCo Recent Developments
Table 114. Nestle Company Information, Head Office, Market Area and Industry Position
Table 115. Nestle Weight-loss Drugs Models, Specifications and Application
Table 116. Nestle Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 117. Nestle Company Profile and Main Business
Table 118. Nestle Recent Developments
Table 119. Amway Corp. Company Information, Head Office, Market Area and Industry Position
Table 120. Amway Corp. Weight-loss Drugs Models, Specifications and Application
Table 121. Amway Corp. Weight-loss Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 122. Amway Corp. Company Profile and Main Business
Table 123. Amway Corp. Recent Developments
List of Figure
Figure 1. Weight-loss Drugs Picture
Figure 2. By Revenue, Global Weight-loss Drugs Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Weight-loss Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Weight-loss Drugs Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Weight-loss Drugs Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Weight-loss Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Weight-loss Drugs Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Weight-loss Drugs Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Weight-loss Drugs Share of Global Market, 2019-2030
Figure 10. Global Weight-loss Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Weight-loss Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Weight-loss Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Weight-loss Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Weight-loss Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Weight-loss Drugs Domestic VS Export, 2022
Figure 16. Global Weight-loss Drugs Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Weight-loss Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Weight-loss Drugs Production Market Share & Forecast by Region, 2019-2030
Figure 19. Weight-loss Drugs Industry Chain
Figure 20. Weight-loss Drugs Procurement Model
Figure 21. Weight-loss Drugs Sales Model
Figure 22. Weight-loss Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Liquid
Figure 24. Powder
Figure 25. Softgels
Figure 26. Pills
Figure 27. Others
Figure 28. By Type, Global Weight-loss Drugs Revenue, 2019-2030, US$ Million
Figure 29. By Type, Global Weight-loss Drugs Revenue Market Share, 2019-2030
Figure 30. By Type, Global Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 31. By Type, Global Weight-loss Drugs Sales Volume Market Share, 2019-2030
Figure 32. By Type, Global Weight-loss Drugs Price, 2019-2030, (US$/Unit)
Figure 33. Online Sales
Figure 34. Hospitals and Clinics
Figure 35. Pharmacy
Figure 36. Others
Figure 37. By Sales Channels, Global Weight-loss Drugs Revenue, 2019-2030, US$ Million
Figure 38. By Sales Channels, Global Weight-loss Drugs Revenue Market Share, 2019-2030
Figure 39. By Sales Channels, Global Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 40. By Sales Channels, Global Weight-loss Drugs Sales Volume Market Share, 2019-2030
Figure 41. By Sales Channels, Global Weight-loss Drugs Price, 2019-2030, (US$/Unit)
Figure 42. By Region, Global Weight-loss Drugs Revenue Market Share, 2019-2030
Figure 43. By Region, Global Weight-loss Drugs Sales Volume Market Share, 2019-2030
Figure 44. North America Weight-loss Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, North America Weight-loss Drugs Revenue Market Share, 2022
Figure 46. Europe Weight-loss Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, Europe Weight-loss Drugs Revenue Market Share, 2022
Figure 48. Asia Pacific Weight-loss Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country/Region, Asia Pacific Weight-loss Drugs Revenue Market Share, 2022
Figure 50. South America Weight-loss Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. By Country, South America Weight-loss Drugs Revenue Market Share, 2022
Figure 52. Middle East & Africa Weight-loss Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 53. U.S. Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, U.S. Weight-loss Drugs Market Share, 2022
Figure 55. By Type, U.S. Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 56. By Sales Channels, U.S. Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 57. Europe Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, Europe Weight-loss Drugs Market Share, 2022
Figure 59. By Type, Europe Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 60. By Sales Channels, Europe Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 61. China Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, China Weight-loss Drugs Market Share, 2022
Figure 63. By Type, China Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 64. By Sales Channels, China Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 65. Japan Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, Japan Weight-loss Drugs Market Share, 2022
Figure 67. By Type, Japan Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 68. By Sales Channels, Japan Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 69. South Korea Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, South Korea Weight-loss Drugs Market Share, 2022
Figure 71. By Type, South Korea Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 72. By Sales Channels, South Korea Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 73. Southeast Asia Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, Southeast Asia Weight-loss Drugs Market Share, 2022
Figure 75. By Type, Southeast Asia Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 76. By Sales Channels, Southeast Asia Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 77. India Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, India Weight-loss Drugs Market Share, 2022
Figure 79. By Type, India Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 80. By Sales Channels, India Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 81. Middle East & Asia Weight-loss Drugs Sales Volume, 2019-2030, (K Units)
Figure 82. By Company, Middle East & Asia Weight-loss Drugs Market Share, 2022
Figure 83. By Type, Middle East & Asia Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 84. By Sales Channels, Middle East & Asia Weight-loss Drugs Sales Volume Market Share, 2022 VS 2029
Figure 85. Research Methodology
Figure 86. Breakdown of Primary Interviews
Figure 87. Bottom-up Approaches
Figure 88. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|